# Rapid Micro Biosystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rapid-micro-biosystems

- Industry: Biotechnology
- Headquarters: Lowell, US
- Website: www.rapidmicrobio.com
- Total disclosed funding: $278M
- Latest round: Series D (Mar 9, 2021)
- Investors on record: 19

## About

Based in Massachusetts, US, and founded in 2006, Rapid Micro Biosystems, Inc. operates as a biotechnology company that focuses on developing products for the detection of microbial contamination. The company was founded by its CEO Robert Spignesi. The company is backed by Adage Capital Management, D1 Capital Partners, Longitude Capital, and T. Rowe Price from venture funding of USD 81 million in March 2021. Rapid Micro Biosystems has raised a total of $358.4M in funding over 10 rounds. Rapid Micro Biosystems is funded by 19 investors.  and has filed to become a public company. 

The company detects microbial contamination, critical in the manufacture of pharmaceuticals, biologics, cell and gene therapies, vaccines, medical devices, and personal care products. The company's line of products includes growth direct, technology, consumables, services, and validation. Rapid Micro Biosystems also offers MQC (Microbial Quality Control) applications such as environmental monitoring (EM), water testing, and bioburden testing that help to improve data integrity and product quality.

Rapid Micro Biosystems plans to continue the global expansion of its platform to improve data integrity and safety in biologics, vaccines, and cell & gene therapy manufacturing. The company also plans to be listed on the Nasdaq under the symbol RPID.

## Funding rounds

- Series D, Mar 9, 2021, $81M — Bain Capital, T Rowe Price, Quaker Partners Management, Endeavour Vision, Adage Capital Management, Longitude Capital, BlackRock, Asahi Kasei Corporation, Ally Bridge Group, Xeraya Capital, Advent Global Opportunities, D1 Capital Partners, CaaS Capital Management
- Series C, Apr 28, 2020, $94M — Bain Capital, Quaker Partners Management, Endeavour Vision, Longitude Capital, Asahi Kasei Corporation, Ally Bridge Group, Xeraya Capital
- Series B, May 2, 2018, $45M — Bain Capital, Quaker Partners Management, TVM Capital Life Science, Richard King Mellon Foundation, Longitude Capital, Asahi Kasei Corporation, Xeraya Capital
- Series C, Apr 21, 2015, $19M — Kleiner Perkins, Quaker Partners Management, TVM Capital Life Science, Longitude Capital, TPG Biotech
- Series B, Apr 4, 2014, $6M — Kleiner Perkins, Quaker Partners Management, TVM Capital Life Science, Longitude Capital, TPG Biotech
- Series B, Jul 9, 2013, $15M — Kleiner Perkins, Quaker Partners Management, TVM Capital Life Science, Longitude Capital, TPG PEP
- Series A, Jul 1, 2009, $19M — Kleiner Perkins, VIMAC Ventures, Quaker Partners Management, TVM Capital Life Science

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B, Series C
- VIMAC Ventures (https://capitalatlas.ai/funds/vimac-ventures) — Series A
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series A, Series B, Series C, Series D
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series A, Series B, Series C
- Longitude Capital (https://capitalatlas.ai/funds/longitude-capital) — Series B, Series C, Series D
- TPG PEP — Series B
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series B, Series C
- Bain Capital (https://capitalatlas.ai/funds/bain-capital) — Series B, Series C, Series D
- Richard King Mellon Foundation — Series B
- Asahi Kasei Corporation — Series B, Series C, Series D
- Xeraya Capital (https://capitalatlas.ai/funds/xeraya-capital) — Series B, Series C, Series D
- Endeavour Vision (https://capitalatlas.ai/funds/endeavour-vision) — Series C, Series D
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series C, Series D
- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series D
- Adage Capital Management — Series D
- BlackRock (https://capitalatlas.ai/funds/blackrock) — Series D
- Advent Global Opportunities (https://capitalatlas.ai/funds/advent-global-opportunities) — Series D
- D1 Capital Partners (https://capitalatlas.ai/funds/d1-capital-partners) — Series D
- CaaS Capital Management (https://capitalatlas.ai/funds/caas-capital-management) — Series D